Suzhou HepaThera Biotech Co., Ltd.
PrivateLast Round
Pre Seed
Feb 1, 2023
Total Funding Raised
$14.7M
Company Overview
Suzhou HepaThera Biotech Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Pre Seed round in February 2023.
Suzhou HepaThera Biotech Co., Ltd. is a biotechnology company that develops innovative therapies for the treatment of liver diseases, including hepatitis B and D.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Suzhou HepaThera Biotech Co., Ltd. Comparables
Compare Suzhou HepaThera Biotech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Hepu Pharmaceutical Co., Ltd. | 82% | |
| Ascletis Pharma Inc. | 76% | |
| HighTide Therapeutics Inc | 73% |
For institutional investors. Book with your work email.
Suzhou HepaThera Biotech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Feb 1, 2023 | ||||
| Seed | Nov 1, 2021 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2023
$15M raised in Pre Seed round.
For institutional investors. Book with your work email.
Suzhou HepaThera Biotech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Suzhou HepaThera Biotech Co., Ltd.'s valuation, stock price, and market status.
Is Suzhou HepaThera Biotech Co., Ltd. a public or private company?
Suzhou HepaThera Biotech Co., Ltd. is a private company.
What is the current stock price of Suzhou HepaThera Biotech Co., Ltd.?
Suzhou HepaThera Biotech Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Suzhou HepaThera Biotech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Suzhou HepaThera Biotech Co., Ltd. worth (valuation)?
Valuation information for Suzhou HepaThera Biotech Co., Ltd. is not publicly available.
Can I buy Suzhou HepaThera Biotech Co., Ltd. stock?
Suzhou HepaThera Biotech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Suzhou HepaThera Biotech Co., Ltd.'s last funding round?
Suzhou HepaThera Biotech Co., Ltd.'s most recent funding round was Pre Seed on February 1, 2023.
Who are the main investors in Suzhou HepaThera Biotech Co., Ltd.?
Investor information for Suzhou HepaThera Biotech Co., Ltd. is not publicly disclosed.
Will Suzhou HepaThera Biotech Co., Ltd. IPO soon?
No public IPO plans have been announced for Suzhou HepaThera Biotech Co., Ltd..
How can I track Suzhou HepaThera Biotech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Suzhou HepaThera Biotech Co., Ltd.'s shares on secondary markets.